Mesirow Financial Investment Management, Inc.
Source: SEC Form 13F · as of Mar 2026Mesirow Financial Investment Management, Inc. holds 10 biotech & pharma companies tracked by BioSniper, totaling $4.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$4.6M
BioSniper AIPage context preserved
Prepared research question
What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 1,702 | $1.3M |
| GILDGILEAD SCIENCES, INC. | 6,770 | $944K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 17,074 | $942K |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 15,430 | $494K |
| IONSIONIS PHARMACEUTICALS INC | 5,460 | $410K |
| FOLDAMICUS THERAPEUTICS, INC. | 13,000 | $188K |
| CSBRCHAMPIONS ONCOLOGY, INC. | 15,800 | $91K |
| INTSINTENSITY THERAPEUTICS, INC. | 14,118 | $83K |
| ESPREsperion Therapeutics, Inc. | 20,000 | $55K |
| LCTXLineage Cell Therapeutics, Inc. | 30,500 | $48K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.